Skip to content

Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company.   Learn more → 

AdminOct 3, 2019< 1 min read

Aetion exec sees real-world evidence, randomized trials playing complementary roles

Aetion President Jeremy Rassen said in an interview on the sidelines of the CB Insights Future of Health conference that rare diseases and Phase IV safety studies would be examples of situations better suited to real-world evidence.

Read More

RELATED ARTICLES